Cell Culture  
 
 
 
   Product List
  Diagnostics
ELISAs
PCR kits
  Research
Antibodies
Cell Biology Assays
Cell Culture
RNA/DNA/Protein Purification
Reagents & Conjugation
Cytokine Immunoassays
Research Immunoassays
Tissues-Proteins
Liquid Handling Systems
  Biotechnology
Glycobiology
Xenobiotics
Toxicology & Mutagenicity
Bioprocess Contamination
  Agri Sciences
GMOs
 
 

Science of Distributing Primary Cells?

 

- Kalpesh Jain, CEO & Marketing-Head

 

The crucial aspect of distributing primary cells has been the logistics and maintenance of the required storage conditions in transit and during transfers.

The most important component of the cells is water. During cryo-preservation, this water is converted to ice and all metabolic activity ceases. Water is the elixir which must be present in the cells in order for chemical reactions to occur within the cell. During the conversion process from water to ice, the cells become dehydrated leading to changes in the salt concentrations and other metabolites that are present. This osmotic imbalance is harmful to the cells and can be highly detrimental during cell recovery. The cell survival is strongly influenced by a number of factors including cooling and thawing rate. Each cell type is optimized for this to ensure that a high number of cells are viable on thawing or revival. Due to the use of a cryo-protective agent, it is crucial to follow the manufacturer’s recommended protocol very strictly for the storage temperature and the thawing rate or protocol.

Lower storage temperatures are associated with extended viability of the preserved samples. While many samples are stored at -80°C, it should be noted that at this temperature metabolic activity has not ceased, it has only slowed down (due to small amounts of unfrozen water). By reducing sample temperatures to below the glass transition phase of water (-132°C), all metabolic activity comes to a halt. Storage below -130°C in liquid nitrogen therefore offers the most secure form of preservation.

Hence we have defined a protocol to store cells in liquid nitrogen and transfer them to end-users in liquid nitrogen vapor-phase cryo-cans. For purposes of our distribution, we use MVE liquid nitrogen vapor-phase cryo-cans with their outside protective shipping cartons.

The SOP for the charging and shipping in these cryo-cans have been defined and standardized with dry validation runs done to different parts of the country. To ensure that strict compliances are done in-house, we have defined parameters during the transfer of the cells in our stores after importing them and during transportation.

These guidelines are adhered to with the help of digital temperature indicators (using hand-held digital indicators). The temperatures are logged to ensure the correct charging has been done. Charging of the vapor phase cryo-cans is also monitored by the amount of liquid nitrogen utilized – prior to charging and post charging.

As pioneers in the country for distribution of primary cells, we bring in the highest standards of quality parameters.

Many users of primary cells have asked us whether they should store the cells in liquid nitrogen or in the vapor phase. In liquid phase, samples are completely submerged in liquid nitrogen at -196°C. However, there are a number of risks associated with direct storage in the liquid phase that need to be highlighted. Storage of samples in glass ampoules is not advised, as during the transition from liquid nitrogen to room temperature, the rapid conversion to a gas phase may cause it to explode.

While the use of plastic screw-cap cryo-tubes minimizes this potential for explosion, during warming, the liquid may still spray from the interface between the cap and the tube. For this reason it is advisable to open cryo-tubes within a contained area. We recommend storing the cells above the liquid nitrogen in the vapor phase at -150°C. This is well below the glass transition phase of -132°C (where all metabolic activity ceases), storage in the vapor phase is therefore both an excellent and safe means of storing them.



References

  • White W and K. Wharton. 1984. Development of a cryogenic preservation system. American Laboratory Oct. 65-76.

  • Wolfinbarger, L., V. Sutherland, L. Braendle, and G. Sutherland. 1996. Engineering aspects of cryobiology, in Advances in Cryogenic Engineering, 41: 1-12.

  • Wolfinbarger L. 1998. The basics of laboratory-scale mammalian cell cryopreservation. BioPharm October 1998: 35-39.

  • Issues in Contamination and Temperature Variation in the Cryopreservation of Animal Cells and Tissues, David W. Burden, Ph.D.

  • Laboratory Procedures for Phages, Guidelines prepared for CABRI by DSMZ in cooperation with NCCB and NCIMB
     

  

  

Promocell GmbH

primary human cells

 


 

 

 

 

 

   
   
 
 
 
  Home About Us Products Services Support Partners Distributor Login Contact Us
 Copyright © 2011 KRISHGEN BioSystems